Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)

Clinical trial NCT00507065 · COMPLETED

Trial details

NCT number

NCT00507065

Sponsor

Shire

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2003-05-28

Primary completion

2004-03-24

Enrollment

329

View on ClinicalTrials.gov